Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: A case report

Gynecologic Oncology

Volumn 92, Issue 1, 2004, Pages 365-367

  Donato, Michele L ^a   Levenback, Charles ^a   Gershenson, David M ^a   McMeekin, Scott ^b   Champlin, Richard E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Allogeneic matched unrelated bone marrow transplantation; Low grade ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIDARABINE;

ABDOMINAL RADIOGRAPHY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTYPE SUPPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHIMERA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DONOR; DRUG RESISTANCE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; LABORATORY TEST; OVARY CARCINOMA; OVARY TUMOR; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; RASH; STEROID THERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 0742307242     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.09.004     Document Type: Article

References (7)

1. Brun J.L., Feyler A., Chene G., Saurel J., Brun G., Hocke C. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol. Oncol. 78:2000;21-27.
2. Lee S.J., Klein J.P., Barrett A.J.et al. Severity of chronic graft-versus-host disease; association with treatment-related mortality and relapse. Blood. 100(2):2002;406-414.
3. Peggs K.S., Makinnon S. Cellular therapy: donor lymphocyte infusion. Curr. Opin. Hematol. 8(6):2001;349-354.
4. Giralt S., Thall P.F., Khouri I.et al. Melphalan and purine analog-containing preparative regimens: reduced intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 97(3):2001;631-637.
5. Childs R., Chernoff A., Contentin N.et al. Regression of metastatic renal-cell carcinoma after non-myeloablative allogeneic peripheral-blood stem-cell transplantation. N. Engl. J. Med. 343(11):2000;750-758.
6. Ueno N.T., Rondon G., Mirza N.Q.et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J. Clin. Oncol. 16(3):1998;986-993.
7. Bay J.O., Fleury J., Choufi B.et al. Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients. Bone Marrow Transplant. 30:2002;95-102.